2Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensivc drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension - 2 study[J ]. Lancet, 1999,354:1751-1756
3Brown MJ,Palmer CR,Castaigne A,et al. Morbidity and mortality in patients randomized to double - blind treatment with a long- acting calcium - channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension T
4Dahlof B, Lindholm LH, Hanson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP- Hypertension) [ J ]. Lancet, 1991,338:1281-1285
5Brown MJ,Castaigne A, de Leeuw PW, et al. Influence of Diabetes and Type of Hypertension on the Response to Antihypertensive Treatment [ J ]. Hypertension, 2000,35:1038-1042
6Mancia, Grassi G. The International Nifedipine GITS Study of Intervention as a Goal in Hypertension Treatment (INSIGHT)trial[J]. American Journal of Cardiology, 1998, 82 (9B): 23R-28R
7Gong L, Zhang W, Zhu Y, et al. Shanghai Trial of Nifedipine in the Elderly (STONE) [J ]. Hypertension, 1996,14:1237-1243
8S. Baba, The J - MIND Study Group. Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type2 diabetics [ J ]. Diabetes Research and Clinical Practice, 2001,54:191-201
9Jan A Staessen, Ji - Guang Wang, Lutgarde Thijs, et al. Cardiovascular protection and blood pressure reduction: a meta- analysis[J ]. Lancet, 2001,358:1305-1315
10Opie LH. Calcium Channel Blockers in Hypertension: Reappraisal after New Trials and Major Meta- Analyses[ J ]. AJH,2001,14:1074-1081
